• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Verily Appoints Myoung Cha as Chief Product Officer

by Executive Life Sciences Appointments 02/08/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Myoung Cha, Chief Product Officer at Verily

What You Should Know:

– Verily, an Alphabet precision health technology company appoints Myoung Cha as Chief Product Officer.

– As Chief Product Officer at Verily, Cha will lead strategy and development across the company’s care (Verily Onduo), research (Verily Viewpoint), and products (Verily Numetric) portfolio.

Cha Bio/Background

Cha has more than twenty years of experience building and implementing innovative technology solutions to advance clinical research, transform patient experiences, and deliver more personalized care. Cha joins Verily from Carbon Health where he served as President and Chief Strategy Officer. In that role, he was responsible for the primary care, virtual care, and mental health service lines and led market access and health system partnerships. He also built and led cross-functional product, engineering, design, clinical, and operations teams to deliver novel primary care models and build new technology-enabled programs and capabilities. 

Prior to Carbon Health, Cha was Head of Health Strategic Initiatives at Apple leading the development and launch of several health engagement technologies focused on improving the health and wellbeing for consumers around the globe, including mobile applications for Apple Watch. Cha also led research studies with leading healthcare organizations, including on atrial fibrillation and early detection of stroke using Apple Watch, and co-developed exposure notification technology with Google to support the COVID-19 pandemic response. Before Apple, he was a Partner at McKinsey & Co where he led McKinsey’s Global Healthcare Strategy & Privacy Equity practices. 

“What excites me about Verily is the unique opportunity we have to advance precision health with the company’s diverse combination of talent, technology, and capabilities,” said Myoung Cha. “Verily’s approach to close the gap between research and care will not only accelerate novel therapies but also generate more robust evidence, resulting in earlier detection and more proactive management of health conditions.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Digital Health Hires

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |